U.S. Markets closed

Synthetic Biologics (SYN) Slumps: Stock Tanks 11.4%

Zacks Equity Research

Synthetic Biologics Inc. (SYN) saw a big move last session, as the company’s shares fell by over 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This stock, trading at a volatile range of $1.53–$1.96 in the past one-month time frame, showed a sharp decline yesterday and dropped to $1.71.

This biotechnology company has seen a flat track record when it comes to current year estimate revisions over the past few weeks as there were no revisions on either side.  The consensus for earnings hasn’t been in trend either. This recent price action is discouraging, so make sure to keep a close watch of this firm in the near future, and especially on earnings estimates following the recent slump.  

SYN currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Biotechnology industry may consider better-ranked stocks like Coronado Biosciences, Inc. (CNDO), Emergent BioSolutions, Inc. (EBS) and Alimera Sciences, Inc. (ALIM). All these stocks carry a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

SYNTHETIC BIOLOGICS INC (SYN): Free Stock Analysis Report

Zacks Investment Research